Stocks News

LAST PRICE
21.0400
TODAY'S CHANGE (%)
Trending Down-0.2800 (-1.3133%)

Bid / Lots
21.0400/ 3
Ask / Lots
21.0500/ 2
Open / Previous Close
21.2200 / 21.3200
Day Range
Low 21.0300
High 21.5600
52 Week Range
Low 21.0300
High 47.4800
Volume
503,055
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Mar 25, 2024
- Update: Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals, from 11:46AM ET on Monday Mar 25, 2024 by MT Newswires
  11:46AM ET on Monday Mar 25, 2024 by MT Newswires
  Companies Mentioned: REGN, NTLA
  11:46 AM EDT, 03/25/2024 (MT Newswires) -- (Updates with Regeneron's response in the third paragraph and the latest stock move of Intellia and Regeneron in the fifth paragraph.) Intellia Therapeutics (NTLA) said in a Friday filing that it has decide...
Mar 22, 2024
- Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals, from 2:11PM ET on Friday Mar 22, 2024 by MT Newswires
  2:11PM ET on Friday Mar 22, 2024 by MT Newswires
  Companies Mentioned: REGN, NTLA
  02:11 PM EDT, 03/22/2024 (MT Newswires) -- Intellia Therapeutics (NTLA) said in a Friday filing that it has decided to end its 2020 agreement with Regeneron Pharmaceuticals (REGN) on developing gene editing products directed to factor IX, a blood cl...

Apr 16, 2024
- Rocket Pharmaceuticals Insider Sold Shares Worth $1,945,785, According to a Recent SEC Filing, from 5:50PM ET on Tuesday Apr 16, 2024 by MT Newswires
  5:50PM ET on Tuesday Apr 16, 2024 by MT Newswires
  Companies Mentioned: RCKT
Apr 11, 2024
- Rocket Pharmaceuticals Insider Sold Shares Worth $308,763, According to a Recent SEC Filing, from 9:10AM ET on Thursday Apr 11, 2024 by MT Newswires
  9:10AM ET on Thursday Apr 11, 2024 by MT Newswires
  Companies Mentioned: RCKT
Apr 4, 2024
- Avidity Biosciences Insider Sold Shares Worth $734,919, According to a Recent SEC Filing, from 10:24AM ET on Thursday Apr 04, 2024 by MT Newswires
  10:24AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: RNA
- Avidity Biosciences Insider Sold Shares Worth $542,214, According to a Recent SEC Filing, from 10:10AM ET on Thursday Apr 04, 2024 by MT Newswires
  10:10AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: RNA
Apr 2, 2024
- Rocket Pharmaceuticals Says European Medicines Agency Accepted Marketing Authorization Application for RP-L102, from 9:45AM ET on Tuesday Apr 02, 2024 by MT Newswires
  9:45AM ET on Tuesday Apr 02, 2024 by MT Newswires
  Companies Mentioned: RCKT
- Goldman Sachs Initiates Rocket Pharmaceuticals at Neutral With $39 Price Target, from 8:00AM ET on Tuesday Apr 02, 2024 by MT Newswires
  8:00AM ET on Tuesday Apr 02, 2024 by MT Newswires
  Companies Mentioned: RCKT
- Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia, from 6:00AM ET on Tuesday Apr 02, 2024 by Business Wire
  6:00AM ET on Tuesday Apr 02, 2024 by Business Wire
  Companies Mentioned: RCKT
Mar 27, 2024
- Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer, from 4:05PM ET on Wednesday Mar 27, 2024 by GlobeNewswire
  4:05PM ET on Wednesday Mar 27, 2024 by GlobeNewswire
  Companies Mentioned: DYN
- Avidity Biosciences to Participate in Upcoming Investor Conferences, from 9:00AM ET on Wednesday Mar 27, 2024 by PR Newswire
  9:00AM ET on Wednesday Mar 27, 2024 by PR Newswire
  Companies Mentioned: RNA
- Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium, from 8:30AM ET on Wednesday Mar 27, 2024 by GlobeNewswire
  8:30AM ET on Wednesday Mar 27, 2024 by GlobeNewswire
  Companies Mentioned: DYN

Intellia Therapeutics Inc
NASDAQ:NTLAUnited States

Search Criteria

Mar 25, 2024

Update: Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals, from 11:46AM ET on Monday Mar 25, 2024 by MT Newswires

Mar 22, 2024

Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals, from 2:11PM ET on Friday Mar 22, 2024 by MT Newswires

Peers Headlines

Apr 16, 2024

Rocket Pharmaceuticals Insider Sold Shares Worth $1,945,785, According to a Recent SEC Filing, from 5:50PM ET on Tuesday Apr 16, 2024 by MT Newswires

Apr 11, 2024

Rocket Pharmaceuticals Insider Sold Shares Worth $308,763, According to a Recent SEC Filing, from 9:10AM ET on Thursday Apr 11, 2024 by MT Newswires

Apr 4, 2024

Avidity Biosciences Insider Sold Shares Worth $734,919, According to a Recent SEC Filing, from 10:24AM ET on Thursday Apr 04, 2024 by MT Newswires

Avidity Biosciences Insider Sold Shares Worth $542,214, According to a Recent SEC Filing, from 10:10AM ET on Thursday Apr 04, 2024 by MT Newswires

Apr 2, 2024

Rocket Pharmaceuticals Says European Medicines Agency Accepted Marketing Authorization Application for RP-L102, from 9:45AM ET on Tuesday Apr 02, 2024 by MT Newswires

Goldman Sachs Initiates Rocket Pharmaceuticals at Neutral With $39 Price Target, from 8:00AM ET on Tuesday Apr 02, 2024 by MT Newswires

Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia, from 6:00AM ET on Tuesday Apr 02, 2024 by Business Wire

Mar 27, 2024

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer, from 4:05PM ET on Wednesday Mar 27, 2024 by GlobeNewswire

Avidity Biosciences to Participate in Upcoming Investor Conferences, from 9:00AM ET on Wednesday Mar 27, 2024 by PR Newswire

Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium, from 8:30AM ET on Wednesday Mar 27, 2024 by GlobeNewswire